Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Gross Profit (2011 - 2018)

Analysis

Cerenome (CNSY) Gross Profit (2011 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Cerenome 20.42 Mn 11.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 230,000.00
Jun 30, 2018 30,000.00
Mar 31, 2018 152,000.00
Dec 31, 2017 29,000.00
Sep 30, 2017 -20,000.00
Jun 30, 2017 262,000.00
Mar 31, 2017 -125,000.00
Dec 31, 2016 521,000.00
Sep 30, 2016 113,000.00
Jun 30, 2016 541,000.00
Mar 31, 2016 766,000.00
Dec 31, 2015 765,000.00
Sep 30, 2015 264,000.00
Jun 30, 2015 318,000.00
Mar 31, 2015 305,000.00
Dec 31, 2014 1.05 Mn
Sep 30, 2014 181,000.00
Jun 30, 2014 169,000.00
Mar 31, 2014 610,000.00
Dec 31, 2013 1.58 Mn